BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2777645)

  • 1. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong.
    Teo P; Tsao SY; Shiu W; Leung WT; Tsang V; Yu P; Lui C
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):515-30. PubMed ID: 2777645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage brachytherapy for patients with locally persistent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; O SK
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):405-12. PubMed ID: 10802367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of early treatment failure in non-metastatic nasopharyngeal carcinoma: a study based on CT scanning.
    Yu KH; Teo PM; Lee WY; Leung SF; Choi PH; Johnson PJ
    Clin Oncol (R Coll Radiol); 1994; 6(3):167-71. PubMed ID: 8086351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography--an analysis of 659 patients.
    Teo P; Shiu W; Leung SF; Lee WY
    Radiother Oncol; 1992 Feb; 23(2):79-93. PubMed ID: 1546192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of the role of intracavitary brachytherapy and prognostic factors determining local tumour control after primary radical radiotherapy in 903 non-disseminated nasopharyngeal carcinoma patients.
    Teo PM; Kwan WH; Yu P; Lee WY; Leung SF; Choi P
    Clin Oncol (R Coll Radiol); 1996; 8(3):160-6. PubMed ID: 8814370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of the use of cisplatinum-5-fluorouracil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma (NPC).
    Teo PM; Leung TW; Chan AT; Yu P; Lee WY; Leung SF; Kwan WH; Johnson P
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):373-9. PubMed ID: 8746267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results of 59 young patients with nasopharyngeal carcinoma.
    Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
    Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study.
    Wei WI; Ho WK; Cheng AC; Wu X; Li GK; Nicholls J; Yuen PW; Sham JS
    Arch Otolaryngol Head Neck Surg; 2001 Dec; 127(12):1457-62. PubMed ID: 11735814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort study.
    Geara FB; Glisson BS; Sanguineti G; Tucker SL; Garden AS; Ang KK; Lippman SM; Clayman GL; Goepfert H; Peters LJ; Hong WK
    Cancer; 1997 Apr; 79(7):1279-86. PubMed ID: 9083147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma.
    Teo PM; Tsao SY; Ho JH; Yu P
    Radiother Oncol; 1991 May; 21(1):11-23. PubMed ID: 1852915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage radiation therapy for locally recurrent nasopharyngeal carcinoma.
    Leung TW; Tung SY; Sze WK; Sze WM; Wong VY; Wong CS; O SK
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1331-8. PubMed ID: 11121630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide variation of probability of local failure and distant metastasis among various stages of patients with nasopharyngeal carcinoma.
    Sakata K; Aoki Y; Karasawa K; Hasezáwa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Strahlenther Onkol; 1994 Apr; 170(4):218-24. PubMed ID: 8165519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
    Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
    Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
    Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
    Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma?
    Gao Y; Zhu G; Lu J; Ying H; Kong L; Wu Y; Hu C
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1397-402. PubMed ID: 20044215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution's 45-year experience.
    Lee N; Hoffman R; Phillips TL; Xia P; Quivey JM; Weinberg V; Hsu IC
    Brachytherapy; 2002; 1(2):74-82. PubMed ID: 15062174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy.
    Chao HL; Liu SC; Tsao CC; Lin KT; Lee SP; Lo CH; Huang WY; Liu MY; Jen YM; Lin CS
    J Radiat Res; 2017 Sep; 58(5):654-660. PubMed ID: 28992206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.